Covid-19: Gennova gets DCGI nod to start Phase II/IIII trials for its mRNA vaccine
Sanjay Singh, CEO of Gennova Biopharmaceuticals, said after establishing the safety of the mRNA-based Covid-19 vaccine candidate HGCO19 in Phase I clinical trial, the company would start Phase II/III clinical trial. Gennova Biopharmaceuticals on Tuesday received approval from the Drugs Controller General of India (DCGI) to start Phase II/III trials for its Covid-19 vaccine. Gennova … Read more